Literature DB >> 31105436

Practices of Care to HIV-Infected Children: Current Situation in Cameroon.

Calixte Ida Penda1,2, Francis A Ndongo3,4, Anne-Cécile Z-K Bissek3,5, Mathurin C Téjiokem6, Casimir Sofeu6,7, Else C Moukoko Eboumbou6,8, Sandrine Mindjouli2, Sophie Desmonde7, Louis R Njock2,9.   

Abstract

BACKGROUND: To accelerate access to pediatric HIV care in Cameroon, operational challenges in implementing HIV pediatric care need to be identified. The aim of this study was to assess the knowledge, attitudes, and practices of health care workers regarding pediatric HIV infection in Cameroon.
METHODS: A descriptive cross-sectional study was conducted over a 4-month period (April to August 2014) in 12 health facilities in 7 regions of Cameroon selected using systematic random sampling. Data were collected from interviews with health care providers and managers using standardized self-administered questionnaires and stored in the ACCESS software.
RESULTS: In total, 103 health care providers were included in this study, of which 59 (57.3%) were health workers and 44 (42.7%) community agents. Most of the health workers in charge of HIV pediatric care were nurses, requiring effective medical task shifting that was institutionalized in Cameroon. The knowledge of health care providers in relation to pediatric HIV care was acceptable. Indications for prescription of test for early infant diagnosis were known (96.1%), but their attitudes and practices regarding initiating antiretroviral therapy (ART) in infants less than 2 years (5.2%) and first-line ART protocols (25.4%) were insufficient, due to little information about standard procedures.
CONCLUSION: Capacity building of health care providers and large-scale dissemination of normative national documents are imperative to improve HIV pediatric care in the health care facilities.

Entities:  

Keywords:  HIV; HIV-infected children; antiretroviral therapy; pediatric care

Year:  2019        PMID: 31105436      PMCID: PMC6501467          DOI: 10.1177/1179556519846110

Source DB:  PubMed          Journal:  Clin Med Insights Pediatr        ISSN: 1179-5565


Introduction

Human immunodeficiency virus (HIV) infection remains a major concern in the world despite the progress recorded in the fields of Prevention of Mother To Child Transmission of HIV (PMTCT) and antiretroviral therapy (ART).[1] In 2012, Africa was the continent most affected by this infection accounting for 91% of HIV-infected children aged less than 15 years.[2] In 2006, the proven effectiveness of early initiation of ART in the first year of life on reducing HIV-related mortality in infants led the World Health Organization (WHO) to recommend routine ART initiation of all HIV-infected infants in 2013.[1] In 2015, this recommendation was, respectively, extended to the children greater than 5 years old and then to every HIV-infected person, irrespective of clinical and immunological stage.[3-6] Moreover, the strategic United Nations AIDS (UNAIDS) 90-90-90 treatment targets aim to have 90% of people living with HIV (PLHIV) knowing their status, 90% ART coverage of PLHIV, and 90% of viral suppression for PLHIV on ART by 2020.[7] These rapidly changing treatment guidelines may contribute to provider confusion and limit knowledge of pediatric HIV care. In resource-limited setting, the mean age at ART initiation was often late and varied between 4 and 9 years, after severe immunodeficiency had set in 70% of cases.[8-10] In 2012, there was a substantial gap between treatment need and access to ART (34%) among the pediatric population, compared with adults (64%) in the 22 priority countries of the Global Plan.[2-6,8-10] This worrisome situation required appropriate solutions and inspired the recommendations of the 2013 WHO pediatric ART guidelines. World Health Organization’s new recommendations raised a new challenge for early infant diagnosis (EID) and access to ART before the age of 24 months. In 2012, only 39% of HIV-exposed infants had access to EID services within the first 2 months of life.[11] Few health facilities developed activities for the care of children to the extent they did for adults. Health care teams, in insufficient numbers, were not trained enough in the field of pediatric HIV.[12,13] In 2012, a small proportion of children in need of ART (15%) were actually on ART, compared with adults (49%) in Cameroon. This gap could be related to poor knowledge of pediatric HIV by health care providers in Cameroon. To accelerate access to pediatric HIV care in Cameroon, it seemed sensible to assess care practices in the health facilities. The aim of this study, therefore, was to assess the knowledge, attitudes, and practices of Cameroonian health care providers on pediatric HIV care.

Methods

Study design

A descriptive cross-sectional study was conducted from April 18 till August 19, 2014 (4 months) in 12 health care facilities offering pediatric HIV care in 7 regions of Cameroon (Center, East, Littoral, North, North-West, West, and South-West).

Selection of the 12 health care facilities

This was based on the assumption that health facilities located in the same environment and covering pediatric populations of similar sizes had the same type of organization and faced similar difficulties. Health care facilities were selected by using a combination of samples techniques: stratified and systematic random sampling. The following variables were considered for sample stratification: urban or rural location and weight of health care facilities. The latter was based on the number of HIV-infected children currently in care and organized in 5 categories: category I (<50 children), category II (between 50 and 150 children), category III (between 150 and 250 children), category IV (between 250 and 350 children), and category V (>350 children). Using the above criteria, the 137 health facilities caring for HIV-infected children in Cameroon were subsequently organized in 4 groups for simplification of sampling: group 1, categories I and II from urban setting (56 health facilities, n = 1728 children, 32%); group 2, categories III to V from urban setting (5 health facilities, n = 2069 children, 39%); group 3, categories I and II from rural setting (74 health facilities, n = 1277 children, 23%); and group 4, categories III to V from rural setting (2 health facilities, n = 324 children, 6%). In each group, health facilities were classified in increasing order based on the number of HIV-infected children currently in care. The sampling interval corresponded to the total number of children in care divided by the number of health facilities to be selected. The later was obtained by applying the percentage of children followed in each group to 12 health facilities: group 1 (n1 = 4), group 2 (n1 = 4), group 3 (n1 = 2), and group 4 (n1 = 1). The selection starting point was determined by pulling randomly a number between 1 and the sampling interval; the first health facility was the one whose accumulated number of HIV-infected children currently in care integrated this value. Finally, the 12 selected health care facilities included the following: 6 Approved Treatment Centers (ATC) belonging to 4 regional hospitals (Bertoua, Garoua, Bafoussam, and Bamenda) and 2 central hospitals (Laquintinie Hospital, Douala, and “Mother and Child Center of the Chantal Biya Foundation,” Yaoundé); 6 treatment units (TU) belonging to 1 regional hospital (South-West regional annex, Limbe) and 3 district hospitals (DH) in Littoral, South-West and North-West regions (“Cité des palmiers” DH, Douala, Kumba DH, Batibo DH), and 2 private hospitals in North-West region (Shisong Catholic Hospital and Mbingo Baptist Hospital, Bamenda).

Study population

Among selected health care facilities, the study population consisted of health care providers in charge of pediatric HIV care including physicians, nurses, psychosocial agents (PSA), community agents, pharmacy clerks, pharmacists, and psychologists who provided written informed consent.

Data Collection

Two standardized and anonymous auto-questionnaires were developed and validated during study preparation meeting including the main investigators and investigators from the Division of Operational Research in Health (DORH) of the Ministry of Public health and from the Center Pasteur du Cameroon (CPC): (1) The “operational level 2” auto-questionnaire administered to the health workers in charge of HIV pediatric care and (2) the “operational level 3” auto-questionnaire administered to community agents in charge of HIV pediatric care. During data collection, an interviewer was always available to guide if necessary the health care providers.

Procedures

The data were collected by 12 interviewers during a 4-months period (April to August 2014) and were entered in an “ACCESS” database by a data administrator of CPC Epidemiology and Public Health Service. The auto-questionnaires were distributed to the staff having consented to participate in the study. The completed auto-questionnaires were validated by the main investigator before data entry.

Ethical Considerations

The administrative authorizations of the Cameroonian Ministry of Public Health (references: No. D21-65/L/MINSANTE/SG/DROS/SPA of March 23, 2014) and various health care facilities were obtained. The study was also approved by the National Ethics Committee for Research in Human Health (No. 2014/03/477/CE/CNERSH/SP, March 29, 2014).

Variables

Using the auto-questionnaires administered to the staff in charge of HIV pediatric care in ATC/TU, the following data were collected: socio-demographic and occupational characteristics (age, sex, function in the health facility, initial training level, number of years at current post), type of services offered from pediatric HIV screening to HIV pediatric care, working conditions, knowledge, attitudes, and practices regarding pediatric HIV care (ART initiation; psychological, social, and nutritional support; HIV status disclosure; and transition to adult service).

Data Analysis

The data were described using frequency and corresponding proportions for categorical variables or medians with interquartile ranges (IQRs) for quantitative variables. The following proportions in relation to health care providers in charge of HIV pediatric care were estimated: knowledge on HIV infection (modes of HIV transmission to children, HIV diagnosis in children, principles of ART initiation, and prevention of opportunistic infections), counseling for HIV screening, and searching for HIV-infected children lost to follow-up. This descriptive analysis was conducted using R software, version 3.4.3.

Results

In total, 103 health care providers from 12 health care facilities participated in this study, of whom 59 (57.2%) were health workers and 44 (42.7%) community agents (Table 1). The median age of the staff was 39.0 years (IQR: 32.0-48.0) and most of them were women (73.9%). The median seniority at the current post was 4.4 years (IQR: 2.0-8.0). More than half (62.1%) of the staff in charge of pediatric HIV have been trained on pediatric HIV care.
Table 1.

Sociodemographic and occupational characteristics of health care providers in charge of HIV pediatric care (Cameroon, 2014), N = 103.

Variablen (%) or median (IQR)
Age (years)39.0 (32.0-48.0)
Female85 (73.9)
Education level
 Primary2 (1.7)
 Secondary53 (46.1)
 Tertiary60 (52.2)
Seniority at the current post (years)4.4 (2.0-8.0)
Initial training level
 Nurse’s aide11 (9.6)
 Social worker6 (5.2)
 Pharmacy assistant6 (5.2)
 Psychosocial agent22 (19.1)
 Nurse33 (28.7)
 Engineer statistician2 (1.7)
 General practitioner19 (16.5)
 Pediatrician4 (3.5)
 Pharmacist0 (0.0)
 Psychologist2 (1.7)
 Assistant laboratory technician10 (8.7)
Previous capacity building in HIV pediatric care64 (62.1)

Abbreviations: n, size in the variable category; IQR, interquartile range.

Sociodemographic and occupational characteristics of health care providers in charge of HIV pediatric care (Cameroon, 2014), N = 103. Abbreviations: n, size in the variable category; IQR, interquartile range.

Knowledge, attitudes, and practices of staff in charge of pediatric HIV

Pediatric HIV prevention and screening

Knowledge of the modes of HIV transmission in children was reported by health care providers as follows: mother to the child (98.1%) and sexual mode of transmission (34.0%). Only 20.5% of the community agents knew the sexual mode of transmission. Most of the staff interviewed (96.1%) reported that pediatric HIV infection is confirmed by a positive polymerase chain reaction (PCR). For health care providers, malnutrition and persistent cough consisted of symptoms of clinical suspicion of HIV in children in the respective proportions of (3.9%) and (1.9%). Counseling for HIV screening in children was reportedly practiced by 92.2% of health workers. Respondents reported the main indications of HIV screening to be HIV-exposed infants and sibling of HIV-infected child (85.4%), hospitalization for severe disease (45.8%), and acute severe malnutrition (ASM; 39.0%). In case of refusal of HIV screening by a parent, a discussion with the second parent, with consent from the first parent, was proposed by 47.6% of the health workers, while a minority (1.7%) reported that they will test the child for HIV without the consent of either parents. About 15.5% of participants reportedly did not carry out any specific activity to identify HIV-exposed infants in the labor room. Medical consultation for HIV-exposed or infected children was reportedly practiced by 76.7% of the health workers. The frequency of HIV-exposed-infants’ visits was reported to be monthly (50.0%) or adjusted to Expanded Program of Immunization (EPI) schedule (32.0%). Among the 47 health workers who implemented specific activities to track HIV-exposed infants, 18.4% of them reportedly used telephone calls (Table 2).
Table 2.

Knowledge, attitudes, and practices of health care providers in charge of HIV pediatric care (Cameroon, 2014).

Knowledge, attitude, and practice assessedLevel of knowledge, attitude, and practice of health care provider
Health workers (N = 59)Community agents (N = 44)All health care providers (N = 103)
Modes of HIV transmission
 Mother to child[a]57 (96.6)44 (100.0)101 (98.1)
 Sexual abuse[a]26 (44.1)9 (20.5)35 (34.0)
 Use of common sharp objects with HIV-infected person1 (1.7)1 (2.3)2 (1.9)
Preventive treatment of infants born to HIV+ mothers on ART
 Nevirapine during breastfeeding period25 (42.4)26 (59.1)51 (49.5)
 Nevirapine for 6 weeks[a]28 (47.5)15 (34.1)43 (41.7)
 Do not know5 (8.5)3 (6.8)8 (7.8)
Suspicion of HIV-infected children
 Positive PCR[a]57 (96.6)42 (95.5)99 (96.1)
 HIV+ mother[a]3 (5.1)1 (2.3)4 (3.9)
 Malnutrition[a]3 (5.1)1 (2.3)4 (3.9)
 History of cough for 3 weeks[a]2 (3.,4)0 (0.0)2 (1.9)
 HIV+ father0 (0.0)1 (2.3)1 (1.0)
 Children with no suggestive sign0 (0.0)2 (4.5)2 (1.9)
Knowledge on HIV mother-to-child transmission risks in children born to HIV+ mothers
 100% of children in the absence of ART in the mother9 (15.3)0 (0.0)0 (0.0)
 30% of children in the absence of ART in the mother[a]17 (28.8)0 (0.0)0 (0.0)
 5% of children if the mother on ART[a]27 (45.8)0 (0.0)0 (0.0)
Administration of co-trimoxazole in HIV-exposed infant
 Independent of age[a]37 (62.7)NANA
 Independent of CD4 count13 (22.0)NANA
 Independent of the viral load6 (10.2)NANA
 Children below the age of 5 years6 (10.2)NANA
Indications of ART initiation in HIV+ child
 Below the age of 2 years[a]3 (5.1)NANA
 HIV+ children with tuberculosis[a]13 (22.0)NANA
 Positive PCR[a]47 (79.7)NANA
 Positive HIV serology[a]21 (35.6)NANA
First-line ART regimen in HIV+ child in case of PMTCT failure
 ABC + 3TC + EFV15 (25.4)NANA
 ABC + DDI + LPV/r4 (6.8)NANA
 AZT + 3TC + NVP22 (37.3)NANA
 3TC + TDF + EFV14 (23.7)NANA
 AZT + 3TC + LVP/r[a]18 (30.5)NANA
 ABC + 3TC + LVP/r[a]15 (25.4)NANA
 Do not know12 (20)NANA
Management of HIV-tuberculosis co-infection
 2 weeks of antituberculous treatment and then ART initiation[a]37 (62.7)NANA
 Antituberculous treatment and ART jointly4 (6.8)NANA
 ART after the end of antituberculous treatment9 (15.3)NANA
 Do not know9 (15.3)NANA
HIV-exposed new born tracking methods in the labor room
 Health care providers dedicated to HIV+ mothers’ deliveries[a]24 (40.7)9 (20.5)33 (32.)
 Linkage formed between the delivery room and the ATC/TU[a]23 (39.0)21 (47.7)44 (42.7)
 Accompanying the mother from maternity to the ATC/TU[a]18 (30.5)20 (45.5)38 (36.9)
 No specific activity in relation to tracking11 (18.6)5 (11.4)16 (15.5)
 Do not know7 (11.9)5 (11.4)12 (11.7)
Practical situations requiring counseling for HIV screening in the child
 Children of a person living with HIV or HIV+ sibling50 (84.7)38 (86.4)88 (85.4)
 Children with severe malnutrition[a]23 (39.0)6 (13.6)29 (28.2)
 Children hospitalized for severe pathology[a]27 (45.8)9 (20.5)36 (35.0)
 Children received at external consultations[a]11 (18.6)5 (11.4)16 (15.5)
Recommended action in case of refusal of HIV screening in the child
 Discussion with the second parent jointly[a]25 (42.4)24 (54.5)49 (47.6)
 Make the parent attend a support group for parent’s HIV+ children[a]21 (35.6)15 (34.1)36 (35.0)
 Refer the parent to another health care provider[a]24 (40.7)17 (38.6)41 (39.8)
 Blood drawn for HIV test in the child without knowing of the parent1 (1.7)0 (0.0)1 (1.0)
Specific follow-up consultation of HIV-exposed infants42 (71.2)37 (84.1)79 (76.7)
Frequency follow-up consultation of HIV-exposed infants
 Documented monthly appointments[a]24 (40.7)28 (63.6)52 (50.5)
 Appointments adjusted to EPI vaccinal calendar[a]22 (37.3)11 (25.0)33 (32.0)
 Verbal appointment at 6 weeks13 (22.0)7 (15.9)20 (19.4)
Health care provider decision to initiate ART in the following context
 Individual decision3 (5.1)NANA
 Adult therapeutic committee31 (52.5)NANA
 Pediatric therapeutic committee[a]21 (35.6)NANA
 Therapeutic committee of the nearest ATC/TU[a]6 (10.2)NANA
 Do not know5 (8.5)NANA
Frequency of medical follow-up of HIV+ children on ART
 Children seen in case of disease8 (13.6)NANA
 Monthly[a]37 (62.7)NANA
 Quarterly[a]12 (20.3)NANA
 Every 6 months9 (15.3)NANA
 Do not know2 (3.4)NANA
HIV status disclosure activity32 (54.2)26 (59.1)58 (56.3)
Age at disclosure
 8-10 years2 (3.4)0 (0.0)2 (2.0)
 11-13 years[a]19 (32.2)14 (31.8)33 (32.0)
 14-17 years11 (18.6)12 (27.3)23 (22.3)
HIV status disclosure issues
 Parents’ reluctance40 (67.8)29 (65.9)69 (67.0)
 Insufficient health care provider skills5 (8.5)9 (20.5)14 (13.6)
 Lack of organization of child preparation10 (16.9)5 (11.4)15 (14.6)
 Other7 (11.,9)3 (6.8)10 (9.7)
Therapeutic education activities32 (54.2)20 (45.5)52 (50.5)
Use of therapeutic education pedagogic tools12 (20.3)12 (27.3)24 (23.3)
Frequency of therapeutic education sessions
 Adhesion consultation before ART initiation and then adherence consultations when necessary12 (20.3)0 (0.0)0 (0.0)
 Adhesion consultation before ART initiation and then adherence consultations every 6 months[a]10 (16.9)0 (0.0)0 (0.0)
 Adherence consultation in case of CD4 count decrease2 (3.4)0 (0.0)0 (0.0)
 Interview not formalized with parent4 (6.8)0 (0.0)0 (0.0)
Psychological follow-up16 (27.1)18 (40.9)34 (33.0)
Psychological follow-up activities
 Therapeutic education by age group[a]0 (0.0)2 (4.5)2 (1.9)
 Counseling[a]11 (18.6)10 (22.7)21 (20.4)
 Psychosocial investigation[a]0 (0.0)1 (2.3)1 (1.0)
 Support group[a]3 (5.1)3 (6.8)6 (5.8)
 Home visit[a]2 (3.4)8 (18.2)10 (9.7)
Specific ways of implementation of the search for HIV+ mothers to do PCR in their infants in the health care facility24 (40.7)23 (52.3)47 (45.6)
Methods of search for HIV+ mothers to do PCR in their infants
 Phone call[a]7 (11.9)10 (22.7)17 (16.5)
 Home visit[a]7 (11.9)1 (2.3)8 (7.8)
 Phone call and home visit[a]9 (15.3)10 (22.7)19 (18.4)
Specific ways of implementation of return of PCR results to the mothers of HIV-exposed infants23 (39)12 (27.3)35 (34.0)
Methods of return of PCR results to the mothers of HIV-exposed infants[a]
 Phone call11 (18.6)8 (18.2)19 (18.4)
 No search undertaken11 (18.6)2 (4.5)13 (12.6)
Methods of identification of children lost to follow-up
 Search for missed appointments in the pharmacy register35 (59.3)20 (45.5)55 (53.4)
 Control of the monthly list HIV+ children waited9 (15.3)10 (22.7)19 (18.4)
 No method undertaken15 (25.4)12 (27.3)27 (26.2)
Method of search for lost to follow-up
 Phone call39 (66.1)35 (79.5)74 (71.8)
 Home visit33 (55.9)29 (65.9)62 (60.2)
 Search for address and phone number of the parent of the child8 (13.6)5 (11.4)13 (12.6)
 No search undertaken6 (10.22 (4.5)8 (7.8)
 Do not know3 (5.1)0 (0.0)3 (2.9)

Abbreviations: ART, antiretroviral treatment; ATC, approved treatment center; EPI, Expanded Program of Immunization; n, size of the variable in the category; NA, not applicable; PCR, polymerase chain reaction; PMTCT, prevention of mother-to-child transmission of HIV; TU, treatment unit.

Recommended attitudes and practices.

Knowledge, attitudes, and practices of health care providers in charge of HIV pediatric care (Cameroon, 2014). Abbreviations: ART, antiretroviral treatment; ATC, approved treatment center; EPI, Expanded Program of Immunization; n, size of the variable in the category; NA, not applicable; PCR, polymerase chain reaction; PMTCT, prevention of mother-to-child transmission of HIV; TU, treatment unit. Recommended attitudes and practices.

Initiation of ART in children

The initiation conditions for ART in HIV-infected children with a positive PCR result were reported by 79.7% of the staff. Other indications for initiation of ART were poorly known by providers, particularly children with serology HIV positive (35.6%) and children co-infected with HIV/TB (22.0%). Only 5.2% of staff knew that HIV-infected infants aged less than 2 years were an indication initiation of ART. The initial ART regimen was prescribed by the health workers without seeking a second opinion (5.1%) or after preliminary validation by the adult therapeutic committee (52.5%), the pediatric therapeutic committee (35.6%), or the closest ATC/TU therapeutic committee (10.2%).

Follow-up of children on ART

On ART initiation, most of the respondents reportedly followed up the children monthly (62.7%), while the rest reported quarterly (20.3%), every 6 months (15.3%), or in case of disease (13.6%) follow-up. The CD4 count was prescribed every 6 months (83.1%) or not at all (8.5%). Viral load exam as a follow-up biomarker was not requested by 40.7% of the health workers. In health facilities offering therapeutic education (50.5%), 34.0% of the health care providers used educational tools. The HIV status disclosure was offered by 56.8% of the sampled health care facilities, and it involved essentially adolescents aged 11 to 17 years (52.3%). The main issues reported by the health workers in implementing this activity were reluctance of the parents/guardians (67.0%), insufficient health workers’ skills (13.6%), and lack of preparation of the child (14.6%). The criteria used to define lost to follow-up varied from 1 to 3 months of absence since the last medical appointment. Some health care providers (26.2%) did not track children lost to follow-up. The national medical file for HIV-infected children was available in the services according to 66.7% of health workers. Among the 66.7% of facilities that offered nutritional support services, 44.7% of them used therapeutic food with local products, either offered free of charge (33.3%) or paid for by the parents/family (44.7%).

Discussion

This is the first study, which aimed to assess the practices of pediatric HIV care in Cameroon. Most of the health workers in charge of pediatric HIV care were nurses, requiring effective medical task shifting, whose efficacy has been proven in Malawi[13] and was institutionalized in Cameroon in 2013. The median seniority at the current post was short (4.4 years [IQR: 2.0-8.0]), showing a high turnover of health care providers in the health care facilities. This situation could prevent health facilities to achieve their goals of care. The knowledge, attitudes, and practices of health care providers were satisfactory in certain aspects of pediatric HIV care but needs to be strengthened. Many facility entry points (maternity, some pathological situations, sexual abuse) which would increase chances of finding pediatric HIV cases were not elicited by the health care providers interviewed, thus portraying some hesitation to propose HIV screening to families with unknown HIV status. Counseling for HIV screening introduced by the health care providers in the entry points of pediatric care is efficient in improving access to health care.[14] Knowledge on many aspects of curative care (ART regimens, management of HIV-tuberculosis co-infection and severe acute malnutrition, and HIV co-morbidities) was limited, translating to a lack of capacity. A little more than a third of health care providers did not receive capacity building in pediatric HIV care. According to 15.5% of health care providers interviewed, there was no specific activity useful in identifying HIV-exposed babies in the labor room. This observation could partly explain the huge proportion of HIV-exposed infants lost to follow-up between the maternity and ATC/TU services in the health care facilities offering EID of HIV. Clear directives must be developed to ensure the continuum of the care between these services.[15] Only 32.0% of health workers coupled HIV-exposed infants’ medical appointments with the EPI vaccination calendar. Nevertheless, this strategy has been strongly recommended in Cameroon since 2008, and studies have shown this strategy to be effective in facilitating the integration of services, reducing risks of stigmatization and decreasing lost to follow-up.[16] Therapeutic education activities remained weakly implemented in the health care facilities offering pediatric HIV care. This situation reflects the difficulty of health care providers in addressing frequent adherence issues among children on ART in resource-limited settings.[17-19] Capacity building of health care providers is imperative to improve psychological and social support of HIV-infected children. This study was conducted in only 12 out of 137 health centers in Cameroon in 7 of the 10 regions of the country. This could pose the problem of representativeness and generalization of results despite random sampling. An observational phase of practices could help minimize potential biases of prevarication or social desirability that could be observed in Knowledge Attitudes Practices (KAP) surveys. Notwithstanding the above, the findings of this study reflected the management practices of most health facilities in Cameroon due to the total number of HIV-infected children (approximately 43% [2257/5300]) on ART in Cameroon in the 12 health facilities included in the study and could be used for the operational plan to accelerate the management of pediatric HIV care.

Conclusions

The knowledge of health care providers of pediatric HIV care was acceptable, but their attitudes and practices were insufficient due to little information concerning the standard procedures. Capacity building of health care providers and large-scale dissemination of normative national documents are imperative to improve HIV pediatric care in health care facilities.
  13 in total

1.  Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in Sub-Saharan Africa.

Authors: 
Journal:  J Acquir Immune Defic Syndr       Date:  2008-12-15       Impact factor: 3.731

2.  Paediatric antiretroviral treatment programmes in sub-Saharan Africa: a review of published clinical studies.

Authors:  Mary-Ann Davies; Matthias Egger; Olivia Keiser; Andrew Boulle
Journal:  Afr J AIDS Res       Date:  2009-10       Impact factor: 1.300

3.  Attitudes and practices of health care workers toward routine HIV testing of infants in Côte d'Ivoire: the PEDI-TEST ANRS 12165 Project.

Authors:  Maxime Aimé Oga; Camille Ndondoki; Hermann Brou; Amadou Salmon; Clarisse Bosse-Amani; Marguerite Timite-Konan; Valériane Leroy
Journal:  J Acquir Immune Defic Syndr       Date:  2011-07-01       Impact factor: 3.731

4.  Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia.

Authors:  Carolyn Bolton-Moore; Mwangelwa Mubiana-Mbewe; Ronald A Cantrell; Namwinga Chintu; Elizabeth M Stringer; Benjamin H Chi; Moses Sinkala; Chipepo Kankasa; Craig M Wilson; Catherine M Wilfert; Albert Mwango; Jens Levy; Elaine J Abrams; Marc Bulterys; Jeffrey S A Stringer
Journal:  JAMA       Date:  2007-10-24       Impact factor: 56.272

5.  Task shifting routine inpatient pediatric HIV testing improves program outcomes in urban Malawi: a retrospective observational study.

Authors:  Eric D McCollum; Geoffrey A Preidis; Mark M Kabue; Emmanuel B M Singogo; Charles Mwansambo; Peter N Kazembe; Mark W Kline
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

6.  Implementing early infant diagnosis of HIV infection at the primary care level: experiences and challenges in Malawi.

Authors:  Queen Dube; Anna Dow; Chawanangwa Chirambo; Jill Lebov; Lyson Tenthani; Michael Moore; Robert S Heyderman; Annelies Van Rie
Journal:  Bull World Health Organ       Date:  2012-06-18       Impact factor: 9.408

Review 7.  Adherence to antiretroviral therapy for pediatric HIV infection: a qualitative systematic review with recommendations for research and clinical management.

Authors:  Jane M Simoni; Arianna Montgomery; Erin Martin; Michelle New; Penelope A Demas; Sohail Rana
Journal:  Pediatrics       Date:  2007-05-28       Impact factor: 7.124

8.  Institutionalizing provider-initiated HIV testing and counselling for children: an observational case study from Zambia.

Authors:  Jane N Mutanga; Juliette Raymond; Megan S Towle; Simon Mutembo; Robert Captain Fubisha; Frank Lule; Lulu Muhe
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

9.  Feasibility of early infant diagnosis of HIV in resource-limited settings: the ANRS 12140-PEDIACAM study in Cameroon.

Authors:  Mathurin C Tejiokem; Albert Faye; Ida C Penda; Georgette Guemkam; Francis Ateba Ndongo; Gisèle Chewa; Claire Rekacewicz; Dominique Rousset; Anfumbom Kfutwah; Pascal Boisier; Josiane Warszawski
Journal:  PLoS One       Date:  2011-07-19       Impact factor: 3.240

10.  Current strategies for improving access and adherence to antiretroviral therapies in resource-limited settings.

Authors:  Michael L Scanlon; Rachel C Vreeman
Journal:  HIV AIDS (Auckl)       Date:  2013-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.